Neuroscience seminars

Open-source tools are gaining an increasing foothold in neuroscience. The rising complexity of experiments in systems neuroscience has led to a need for multiple parts of experiments to work together seamlessly. This means that open-source tools that freely interact with each other and can be understood and modified more easily allow scientists to conduct better experiments with less effort than closed tools. Open Ephys is an organization with team members distributed all around the world. Our mission is to advance our understanding of the brain by promoting community ownership of the tools we use to study it. We are making and distributing cutting edge tools that exploit modern technology to bring down the price and complexity of neuroscience experiments. A large component of this is to take tools that were developed in academic labs and helping with documentation, support, and distribution. More recently, we have been working on bringing high-quality manufacturing, distribution, warranty, and support to open source tools by partnering with OEPS in Portugal. We are now also establishing standards that make it possible to combine methods, such as miniaturized microscopes, electrode drive implants, and silicon probes seamlessly in one system. In the longer term, our development of new tools, interfaces and our standardization efforts have the goal of making it possible for scientists to easily run complex experiments that span from complex behaviors and tasks, multiple recording modalities, to easy access to data processing pipelines.

Integrated information theory (IIT) takes as its starting point phenomenology, rather than behavioral, functional, or neural correlates of consciousness. The theory characterizes the essential properties of phenomenal existence—which is immediate and indubitable. These are translated into physical properties, expressed operationally as cause-effect power, which must be satisfied by the neural substrate of consciousness. On this basis, the theory can account for clinical and experimental data about the presence and absence of consciousness. Current work aims at accounting for specific qualities of different experiences, such as spatial extendedness and the flow of time. Several implications of IIT have ethical relevance. One is that functional equivalence does not imply phenomenal equivalence—computers may one day be able to do everything we do, but they will not experience anything. Another is that we do have free will in the fundamental, metaphysical sense—we have true alternatives and we, not our neurons, are the true cause of our willed actions.

Agent-causal libertarian free will asserts that the conscious agent is the ultimate cause of her own voluntary behavior. A major reason to reject libertarian free will is that it seems incompatible with our current knowledge of physics. In this talk I will argue how quantum processes, specifically non-random collapses of the wavefunction in the human cortex, may enable libertarian free will. I will discuss how this account can be empirically tested.

The ventral visual pathway extends from the occipital to the anterior temporal regions, and is specialized in giving meaning to objects and people that are perceived through vision. Numerous studies in functional magnetic resonance imaging have focused on the cerebral basis of visual recognition. However, this technique is susceptible to magnetic artefacts in ventral anterior temporal regions and it has led to an underestimation of the role of these regions within the ventral visual stream, especially with respect to face recognition and semantic representations. Moreover, there is an increasing need for implicit methods assessing these functions as explicit tasks lack specificity. In this talk, I will present three studies using fast periodic visual stimulation (FPVS) in combination with scalp and/or intracerebral EEG to overcome these limitations and provide high SNR in temporal regions. I will show that, beyond face recognition, FPVS can be extended to investigate semantic representations using a face-name association paradigm and a semantic categorisation paradigm with written words. These results shed new light on the role of temporal regions and demonstrate the high potential of the FPVS approach as a powerful electrophysiological tool to assess various cognitive functions in neurotypical and clinical populations.

In human and non-human animals, conceptual knowledge is partially organized according to low-dimensional geometries that rely on brain structures and computations involved in spatial representations. Recently, two separate lines of research have investigated cognitive maps, that are associated with the hippocampal formation and are similar to world-centered representations of the environment, and image spaces, that are associated with the parietal cortex and are similar to self-centered spatial relationships. I will suggest that cognitive maps and image spaces may be two manifestations of a more general propensity of the mind to create low-dimensional internal models, and may play a role in analogical reasoning and metaphorical thinking. Finally, I will show some data suggesting that the metaphorical relationship between colors and emotions can be accounted for by the structural alignment of low-dimensional conceptual spaces.

Neural correlates of visual working memory have been found in early visual, parietal, and prefrontal regions. These findings have spurred fruitful debate over how and where in the brain memories might be represented. Here, I will present data from multiple experiments to demonstrate how a focus on behavioral requirements can unveil a more comprehensive understanding of the visual working memory system. Specifically, items in working memory must be maintained in a highly robust manner, resilient to interference. At the same time, storage mechanisms must preserve a high degree of flexibility in case of changing behavioral goals. Several examples will be explored in which visual memory representations are shown to undergo transformations, and even shift their cortical locus alongside their coding format based on specifics of the task.

Monetary incentive delay task (MID) is a well-validated human functional MRI task widely used in probing affective-motivational processes in psychiatric disorders. We are developing a mouse version of the MID task in order to facilitate translations of findings from the wealth of human imaging studies. This talk presents our task design and behavioural data from the ongoing work.

Threshold-linear networks (TLNs) are popular firing rate models of recurrent networks. They have been used to model associative memory, decision-making, and position coding in cortical and hippocampal networks. Unlike rate models with other choices of nonlinearity, TLNs are piecewise linear, making them more amenable to mathematical analysis. In this talk I will present ten theorems about TLNs from the past five years. Many of these theorems connect the fixed points of a network to the structure of an underlying connectivity graph. These results have enabled us to develop graph rules to predict both static and dynamic attractors from network motifs. The theorems will be complemented with examples that illustrate how the mathematical results can be used to analyze and design recurrent networks that support a rich variety of computations and dynamics. Examples include internally-generated sequences, neural integrators, and central pattern generator circuits. Presented in the van Vreeswijk Theoretical Neuroscience Seminar series (formerly WWTNS) on 2021-06-23. Recording duration: 00:53:51.

Neural computations occurring simultaneously in multiple cerebral cortical regions are critical for mediating behaviors. Progress has been made in understanding how neural activity in specific cortical regions contributes to behavior. However, there is a lack of tools that allow simultaneous monitoring and perturbing neural activity from multiple cortical regions. We have engineered a suite of technologies to enable easy, robust access to much of the dorsal cortex of mice for optical and electrophysiological recordings. First, I will describe microsurgery robots that can programmed to perform delicate microsurgical procedures such as large bilateral craniotomies across the cortex and skull thinning in a semi-automated fashion. Next, I will describe digitally designed, morphologically realistic, transparent polymer skulls that allow long-term (>300 days) optical access. These polymer skulls allow mesoscopic imaging, as well as cellular and subcellular resolution two-photon imaging of neural structures up to 600 µm deep. We next engineered a widefield, miniaturized, head-mounted fluorescence microscope that is compatible with transparent polymer skull preparations. With a field of view of 8 × 10 mm2 and weighing less than 4 g, the ‘mini-mScope’ can image most of the mouse dorsal cortex with resolutions ranging from 39 to 56 µm. We used the mini-mScope to record mesoscale calcium activity across the dorsal cortex during sensory-evoked stimuli, open field behaviors, social interactions and transitions from wakefulness to sleep.

My laboratory studies how the retina processes visual scenes and transmits this information to the brain. We use multi-electrode arrays to record the activity of hundreds of retina neurons simultaneously in conjunction with transgenic mouse lines and chemogenetics to manipulate neural circuit function. We are interested in three major areas. First, we work to understand how neurons in the retina are functionally connected. Second we are studying how light-adaptation and circadian rhythms alter visual processing in the retina. Finally, we are working to understand the mechanisms of retinal degenerative conditions and we are investigating potential treatments in animal models.

In this lecture, Dr Stevens will discuss recent work that implicates brain immune cells, called microglia, in sculpting of synaptic connections during development and their relevance to autism, schizophrenia and other brain disorders. Her recent work revealed a key role for microglia and a group of immune related molecules called complement in normal developmental synaptic pruning, a normal process required to establish precise brain wiring. Emerging evidence suggests aberrant regulation of this pruning pathway may contribute to synaptic and cognitive dysfunction in a host of brain disorders, including schizophrenia. Recent research has revealed that a person’s risk of schizophrenia is increased if they inherit specific variants in complement C4, gene plays a well-known role in the immune system but also helps sculpt developing synapses in the mouse visual system (Sekar et al., 2016). Together these findings may help explain known features of schizophrenia, including reduced numbers of synapses in key cortical regions and an adolescent age of onset that corresponds with developmentally timed waves of synaptic pruning in these regions. Stevens will discuss this and ongoing work to understand the mechanisms by which complement and microglia prune specific synapses in the brain. A deeper understanding of how these immune mechanisms mediate synaptic pruning may provide novel insight into how to protect synapses in autism and other brain disorders, including Alzheimer’s and Huntington’s Disease.

Diseases that arise from misfolding of an individual protein are rare. However, collectively, these folding diseases represent a large proportion of hereditary and acquired disorders. In fact, the term "Molecular Medicine" was coined by Linus Pauling in conjunction with the study of a folding disease, i.e. sickle cell anemia. In the past decade, we have witnessed an exponential growth in the number of mutations, which have been identified in genes encoding solute carriers (SLC). A sizable faction - presumably the majority - of these mutations result in misfolding of the encoded protein. While studying the export of the GABA transporter (SLC6A1) and of the serotonin transporter (SLC6A4), from the endoplasmic reticulum (ER), we discovered by serendipity that some ligands can correct the folding defect imparted by point mutations. These bind to the inward facing state. The most effective compound is noribogaine, the metabolite of ibogaine (an alkaloid first isolated from the shrub Tabernanthe iboga). There are 13 mutations in the human dopamine transporter (DAT, SLC6A3), which give rise to a syndrome of infantile Parkinsonism and dystonia. We capitalized on our insights to explore, if the disease-relevant mutant proteins were amenable to pharmacological correction. Drosopohila melanogaster, which lack the dopamine transporter, are hyperactive and sleepless (fumin in Japanese). Thus, mutated human DAT variants can be introduced into fumin flies. This allows for examining the effect of pharmacochaperones on delivery of DAT to the axonal territory and on restoring sleep. We explored the chemical space populated by variations of the ibogaine structure to identify an analogue (referred to as compound 9b), which was highly effective: compound 9b also restored folding in DAT variants, which were not amenable to rescue by noribogaine. Deficiencies in the human creatine transporter-1 (CrT1, SLC6A8) give rise to a syndrome of intellectual disability and seizures and accounts for 5% of genetically based intellectual disabilities in boys. Point mutations occur, in part, at positions, which are homologous to those of folding-deficient DAT variants. CrT1 lacks the rich pharmacology of monoamine transporters. Nevertheless, our insights are also applicable to rescuing some disease-related variants of CrT1. Finally, the question arises how one can address the folding problem. We propose a two-pronged approach: (i) analyzing the effect of mutations on the transport cycle by electrophysiological recordings; this allows for extracting information on the rates of conformational transitions. The underlying assumption posits that - even when remedied by pharmacochaperoning - folding-deficient mutants must differ in the conformational transitions associated with the transport cycle. (ii) analyzing the effect of mutations on the two components of protein stability, i.e. thermodynamic and kinetic stability. This is expected to provide a glimpse of the energy landscape, which governs the folding trajectory.